Clinical trial
Sunitinib in Refractory Adrenocortical-Carcinoma Patients Progressing After Cytotoxic Chemotherapy
NCT00453895 is registered in ClinicalTrials.gov with University of Wuerzburg as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Sunitinib in Refractory Adrenocortical-Carcinoma Patients Progressing After Cytotoxic Chemotherapy
- Lead sponsor
- University of Wuerzburg
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- July 31, 2007
- Completion date
- February 29, 2012
- Enrollment
- 39 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.